IP Library › Granted Patent US 11,324,550
Granted Patent B2
US 11,324,550 · App. 16/195,249 · Granted May 10, 2022

System and method for assessing effective delivery of ablation therapy

Inventors: D. Curtis Deno (Andover, MN); Stephan P. Miller (Vadnais Heights, MN)
Assignee: St. Jude Medical, Atrial Fibrillation Division, Inc.
A61B18/1492A61B5/068A61B5/4848A61B5/6843A61B5/6844A61B5/6885A61B5/743A61B90/37A61B5/01A61B5/0538A61B18/02A61B2017/00044A61B2017/00199A61B2018/00351A61B2018/00577A61B2018/00642A61B2218/002A61N7/022
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,324,550
App. No.
16/195,249
Granted
May 10, 2022
Kind
B2
Abstract

A system and method for assessing effective delivery of ablation therapy to a tissue in a body is provided. A three-dimensional anatomical map of the tissue is generated and displayed with the map defining a corresponding volume. An index is generated corresponding to a location within the volume with the index indicative of a state of ablation therapy at the location. The index may be derived from one or more factors such as the duration an ablation electrode is present at the location, the amount of energy provided, the degree of electrical coupling between an ablation electrode and the tissue at the location and temperature. A visual characteristic (e.g., color intensity) of a portion of the anatomical map corresponding to the location is then altered responsive to the index.

Claims (55)

1. A system for assessing effective delivery of ablation therapy to a tissue in a body, comprising:

an electronic control unit (ECU) configured to generate a map of the tissue; wherein the ECU is further configured to:

receive a threshold value for a factor indicative of delivery of ablation energy;

acquire a value for the factor at a first location on the map;

compare the acquired value to the threshold value;

determine an index based on the acquired value;

generate a first visual characteristic at the first location, using the index, if the acquired value exceeds the threshold value; and

generate a second visual characteristic at the first location, using the index, if the acquired value does not exceed the threshold value.

2. The system of claim 1 , wherein the factor indicative of delivery of ablation energy is selected from the group consisting of:

an amount of energy delivered at the first location;

a duration of time during which an ablation electrode is present at the first location;

a duration of time during which an ablation electrode is away from the first location;

an impedance measurement proximate a distal end of the ablation electrode;

a maximum amount of power delivered at the first location;

an average amount of power delivered at the first location;

an average temperature proximate a distal end of the ablation electrode;

a maximum temperature proximate a distal end of the ablation electrode;

an average contact force between the ablation electrode and the tissue; and

a maximum contact force between the ablation electrode and the tissue.

3. The system of claim 1 , wherein the first visual characteristic is a first color and the second visual characteristic is a second color wherein the second color is different from the first color.

4. The system of claim 1 , wherein the first visual characteristic is a first color with a first color intensity and the second visual characteristic is the first color with a second color intensity, wherein the second color intensity is different form the first color intensity.

5. The system of claim 4 , wherein a difference between the first color intensity and the second color intensity are non-linear with respect to the index.

6. The system of claim 1 , wherein the first visual characteristic is a first state and the second visual characteristic is a second state, wherein the second state is different from the first state.

7. The system of claim 1 , wherein the ECU is further configured to superimpose a marker at the first location.

8. The system of claim 1 , wherein the ECU is further configured to:

apply a first function to a first range of the index; and

apply a second function is to a second range of the index;

wherein the first function is different from the second function, and wherein the first function and the second function comprise one or more of applying a color, changing a state, and changing a color intensity.

9. A method for assessing effective delivery of ablation therapy to a tissue in a body, comprising:

receiving, by an electronic control unit (ECU) configured to generate a map of the tissue, a threshold value for a factor indicative of delivery of ablation energy;

acquiring, by the ECU, a value for the factor at a first location on the map;

comparing, by the ECU, the acquired value to the threshold value;

determining, by the ECU, an index based on the acquired value;

generating a first visual characteristic at the first location, using the index, if the acquired value exceeds the threshold value; and

generating a second visual characteristic at the first location, using the index, if the acquired value does not exceed the threshold value.

10. The method of claim 9 , wherein the factor indicative of delivery of ablation energy is selected from the group consisting of:

an amount of energy delivered at the first location;

a duration of time during which an ablation electrode is present at the first location;

a duration of time during which an ablation electrode is away from the first location;

an impedance measurement proximate a distal end of the ablation electrode;

a maximum amount of power delivered at the first location;

an average amount of power delivered at the first location;

an average temperature proximate a distal end of the ablation electrode;

a maximum temperature proximate a distal end of the ablation electrode;

an average contact force between the ablation electrode and the tissue; and

a maximum contact force between the ablation electrode and the tissue.

11. The method of claim 9 , wherein the first visual characteristic is a first color and the second visual characteristic is a second color, wherein the second color is different from the first color.

12. The method of claim 9 , wherein the first visual characteristic is a first color with a first color intensity and the second visual characteristic is the first color with a second color intensity, wherein the second color intensity is different form the first color intensity.

13. The method of claim 9 , wherein the first visual characteristic is a first state and the second visual characteristic is a second state, wherein the second state is different from the first state.

14. The method of claim 13 , wherein a difference between the first color intensity and the second color intensity is non-linear with respect to the index.

15. The method of claim 9 , wherein the ECU is further configured to superimpose a marker at the first location.

16. The method of claim 9 , further comprising:

applying, by the ECU, a first function to a first range of the index; and

applying, by the ECU, a second function is to a second range of the index;

wherein the first function is different from the second function, and wherein the first function and the second function comprise one or more of applying a color, changing a state, and changing a color intensity.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2019
From: DENO, D. CURTIS; MILLER, STEPHAN P.
To: ST. JUDE MEDICAL, ATRIAL FIBRILLATION DIVISION, INC.
Reel/Frame 049337/0400 →
Continuity (4)
Division 14872208 · Oct 1, 2015
Continuation 13889732 · May 8, 2013
Continuation 12622626 · Nov 20, 2009
Related Publication 20190151014A1 · May 23, 2019
Cited By (1)
US 12,740,826